RX Series Copper (Cu) Assay Ref. Number CU2340
Published February 14, 2024 · Recall initiated: November 29, 2023
Summary
FDA records medical device Class II recall Z-0992-2024, published February 14, 2024 and initiated November 29, 2023. Recalling firm: Randox Laboratories Ltd.; Status: Ongoing; Reported quantity: 3,053 kits (2 US, 3,051 OUS); Lot: Catalogue Number/GTIN: CU2340 05055273201949; Lot/batch: 592278, 610661, 610669, 629021, 647201, 657944. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper assay is run after total protein it could lead to falsely elevated copper results.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Randox Laboratories Ltd.
- Distributor
- US Nationwide distribution in the states of SC and OK.
- Lot
- Catalogue Number/GTIN: CU2340 05055273201949; Lot/batch: 592278, 610661, 610669, 629021, 647201, 657944;
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Ireland
Related recalls
- FDARX Series CYSC- Cystatin C Reagent -Intended for in vitro diagnostic (IVD) use as Randox Cystatin C assay onJuly 31, 2024
- FDAClinical Chemistry Calibration Serum (Catalog number Cal2351) that is 20x5ml lyophilized human based serumMay 15, 2024
- FDAEvidence MultiSTAT with software v 3.7-Analyzer intended for the qualitative determination of parent drugMay 15, 2024
- FDAMicroalbumin Calibrator Series (mALB CAL)-IVD to calibrate the Microalbumin Assay Catalog Number: MA2426April 24, 2024
- FDAFlow-e Anesthesia System, model 6887900February 14, 2024
- FDAFilmArray Pneumonia Panel Plus (Pneumoplus), REF: RFIT-ASY-0143, CED 2797, IVD, Rx Only (30 test kit)February 14, 2024
Questions about this recall
Was RX Series Copper (Cu) Assay Ref. Number CU2340 recalled?
Yes. FDA published recall Z-0992-2024 on February 14, 2024. Reported hazard: Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper assay is run after total protein it could lead to falsely elevated copper results.
What should I do if I have this product?
Voluntary: Firm initiated · Letter